Tff Pharmaceuticals Inc

NASDAQ:TFFP   3:59:51 PM EDT
8.68
+0.03 (+0.35%)
Products, Regulatory

TFF Pharmaceuticals Announces Completion Of Preliminary Data From Its Phase 1 Clinical Trial Of Tacrolimus Inhalation Powder

Published: 07/13/2021 12:16 GMT
Tff Pharmaceuticals Inc (TFFP) - Tff Pharmaceuticals Announces Completion of Enrollment and Preliminary Data From Its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder.
Tff Pharmaceuticals Inc - Initiation of Lung Transplant Study Expected in 2h 2021.
Tff Pharmaceuticals Inc - Inhaled Tacrolimus Powder Achieves Systemic Therapeutic Drug Levels.
Tff Pharmaceuticals Inc - Anticipate Additional Safety Data in 3q 2021.